The Board of Directors of Blue Cross Blue Shield of Massachusetts (BCBSMA) has chosen Executive Vice President Andrew Dreyfus as the company's new president and chief executive officer. Dreyfus succeeds Bill Van Faasen who has served in an unpaid interim role of president and CEO since March 16, 2010.
The Board of Directors of Blue Cross Blue Shield of Massachusetts (BCBSMA) has chosen Executive Vice President Andrew Dreyfus as the company's new president and chief executive officer. Dreyfus succeeds Bill Van Faasen who has served in an unpaid interim role of president and CEO since March 16, 2010. Van Faasen will remain involved with the company in a role still to be determined.
"Andrew is not only an experienced leader in the industry and a nationally known expert on critical issues such as health reform and changing the way we pay for care, but as importantly, he has a broad understanding and passionate commitment to continuing and strengthening the important leadership role BCBSMA has played in our community since the company's founding 73 years ago," said BCBSMA Board Chairman Paul Guzzi in a statement announcing the decision.
Over the past five years, Dreyfus has served as BCBSMA's executive vice president for Health Care Services. He also led the development and execution of the company's Alternative Quality Contract (AQC), a new payment model that aligns physician and hospital payments with the quality of care patients receive.
Dreyfus has been a part of BCBSMA's executive leadership team since 2001, when he was selected as the first president of the Blue Cross Blue Shield of Massachusetts Foundation. Prior to joining BCBSMA in 2001, Dreyfus was an executive vice president at the Massachusetts Hospital Association and held senior positions in the Massachusetts Executive Office of Human Services and the Executive Office of Consumer Affairs and Business Regulation.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent
June 19th 2025Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be available to the people who would benefit most from HIV PrEP?
Read More